What’s Evaluated in a Stability Study?
By Corey Ohnmacht, Suzanne Jansen
August 5, 2025
Looking at the importance of stability programs in early clinical drug product development.
3 min read
False
Advertisement
Formulation
Is The Generics Industry in Need of a Value Makeover?
By Ben Ellis
July 10, 2025
The role of generic medicines in reducing costs, improving access, and saving lives.
4 min read
New Weight-Loss Drug Aims for Results Without Harsh GI Effects
July 2, 2025
A new dual agonist GLP-1 is showing weight loss without gastrointestinal side effects and appetite suppression. We speak with the company to learn more.
3 min read
Unpacking the GLP-1 Gold Rush
June 30, 2025
We ask experts for their views on the GLP-1 market in this exclusive eBook.
1 min read
Can AI Help Solve the Solubility Challenge?
June 9, 2025
We explore how AI-based tools are making a mark in formulation by improving solubility
10 min read
Psoriasis: More Than Skin Deep
By Rob Coker
June 4, 2025
Recent developments in the treatment of psoriasis has brought new hope to sufferers, and a surge in market standings.
4 min read
A Career of Antibody Drug Conjugates
By Stephanie Vine
May 30, 2025
From different modalities to overcoming aggregation; we find out what advances are affecting the development of ADCs.
3 min read
Towards Spray Dried RNA Vaccines
By Stephanie Vine
May 16, 2025
Biotech company Ethris explains the benefits and challenges of developing spray dried RNA vaccines.
5 min read
Oral Alternatives for Injectable IV Medicines
By Stephanie Vine
May 7, 2025
Researchers say they have found a method that will allow some large molecules to be administered orally
2 min read
Tackling the Nasal Membrane Challenge
By Stephanie Vine
May 6, 2025
What’s going on in nasal drug delivery? We spoke with Kim Earnst, VP of product development and laboratory service at Renaissance Lakewood to get a glimpse of the latest trends and challenges in the area.
3 min read
